Exploring the repurposing potential of β2-adrenergic receptor agonists for cognitive function: Evidence from the PharmLines Initiative Retrospective Cohort Study
Background: Preclinical studies suggest β2-adrenergic receptor agonists may exert neuroprotective effects, but evidence in human populations is limited. Objective: To examine the association between β2-adrenergic receptor agonist use and cognitive performance in older adults. Methods: This […]
